AzTrials
AzTrials

Mobility LimitationEarly Phase 1NCT04446455

A Pilot to Evaluate the Feasibility and Efficacy of a Multifaceted Rehabilitation Intervention

A Early Phase 1 study testing InVEST: Increased Velocity Exercise Specific to Task and TAPAT: Tonic and Phasic Alertness Training in people with Mobility Limitation, run by VA Boston Healthcare System at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this study is to evaluate the efficacy of multifaceted rehabilitation program in Veterans 65 years and older. This study will also examine the neuromuscular and cognitive attributes that contribute to clinically meaningful improvements in mobility; and determine whether a novel mode of cognitive training… Read more about this study

Who is it for?
Ages 65 to 90 yearsHealthy volunteers can take part
Conditions the study is for
Mobility Limitation
What is being tested?
InVEST: Increased Velocity Exercise Specific to Task and TAPAT: Tonic and Phasic Alertness Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteUnited States
Study dates
1 May 2018to 15 Nov 2018
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • Age 65-90
  • History of fall in the past year OR difficulty or task modification with climbing one flight of stairs or walking ½ mile (6 blocks)
  • Community Dwelling
  • Ability to speak and understand English

Who cannot join

  • Presence of a terminal disease (e.g. receiving hospice services, metastatic cancer
  • Major medical problem interfering with safe and successful testing (i.e. history of hip replacement with recurrent dislocation; uncontrolled hypertension, use of supplemental oxygen
  • Myocardial infarction or major surgery in previous 3 months
  • Planned major surgery (e.g. joint replacement)
  • Baseline Short Physical Performance Battery Score <4 or >10
  • Modified Mini Mental Status Examination score of ≤77 out of 100
  • Inability to safely complete the 400 meter walk test

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VA Boston Healthcare System

    Boston, Massachusetts, 02130

Other trials in United States

About this study

The goal of this study is to evaluate the efficacy of multifaceted rehabilitation program in Veterans 65 years and older. This study will also examine the neuromuscular and cognitive attributes that contribute to clinically meaningful improvements in mobility; and determine whether a novel mode of cognitive training can enhance cognition among mobility limited primary care Veterans 65 years and older.

Read the detailed description

This study is a randomized control pilot study. All participants will receive rehabilitative exercise addressing mobility skills. In addition, one group will be will receive additional cognitive training. Randomization is stratified according to screening mobility and cognitive score.

Being tested
InVEST: Increased Velocity Exercise Specific to Task, TAPAT: Tonic and Phasic Alertness Training
Keywords
Rehabilitation, Aging, Mobility Skills, Cognitive Training
Medical subject headings
Mobility Limitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • InVEST: Increased Velocity Exercise Specific to TaskOther

    Functional Power Training

  • TAPAT: Tonic and Phasic Alertness TrainingOther

    Computerized cognitive training.

Study groups in NCT04446455
Study groupRoleWhat they receive
Functional Power + Cognitive TrainingExperimentalTraining sessions began with approximately 30 minutes of cognitive training using a desktop computer followed by 40 minutes of functional power training.
Receives: Other: InVEST: Increased Velocity Exercise Specific to Task; Other: TAPAT: Tonic and Phasic Alertness Training
Functional Power TrainingActive comparatorTraining sessions began with 40 minutes of functional power training.
Receives: Other: InVEST: Increased Velocity Exercise Specific to Task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline Late-Life Function and Disability Instrument at 6 weeks

    Function domain and the advanced and basic lower extremity function sub-domains of the Late-Life Function and Disability Instrument

    Measured: Baseline, 6 weeks

Secondary outcomes (8)
  1. Change from Baseline Figure-of-8 Performance 6 weeks

    Measured: Baseline, 6 weeks

  2. Change from Baseline 400 Meter Walk Test at 6 weeks

    Measured: Baseline, 6 weeks

  3. Change from Baseline Short Physical Performance Battery (SPPB) at 6 weeks

    Range: 0-12; higher score better physical performance

    Measured: Baseline, 6 weeks

  4. Change from Baseline Cognitive Performance at 6 weeks

    Measured: Baseline, 6 weeks

  5. Change from Baseline Trail Making Test at 6 weeks

    Measured: Baseline, 6 weeks

  6. Change from Baseline Clock-in-the-Box Test at 6 weeks

    Measured: Baseline, 6 weeks

  7. Change from Baseline Letter Fluency Test at 6 weeks

    Measured: Baseline, 6 weeks

  8. Change from Baseline Hopkins Verbal Learning Test at 6 weeks

    Measured: Baseline, 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jun 2020
  2. Study start1 May 2018
  3. Primary completion15 Nov 2018
  4. Study completion15 Nov 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized Pilot Study
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04446455
Sponsor's protocol ID
3014
Status last verified
Jun 2020
First submitted
16 Jun 2020
Last updated
25 Jun 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing InVEST: Increased Velocity Exercise Specific to Task and TAPAT: Tonic and Phasic Alertness Training in people with Mobility Limitation, run by VA Boston Healthcare System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline Late-Life Function and Disability Instrument at 6 weeks (time frame: Baseline, 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in